TheJobsMapAbout KSQ Therapeutics
KSQ Therapeutics has built an industry-leading genome-scale precision functional genomics platform, called CRISPRomics, to pinpoint therapeutic nodes that directly correlate genomic function to disease with unprecedented certainty and speed.
Founded in 2015 by David Berry and David Sabatini.
- Founded
- 2015
- Employees
- 11 to 50
- Total funding
- $156M
- Headquarters
- Cambridge
Leadership
The top of KSQ Therapeutics's org chart, with how many people report into each leader.
Qasim Rizvi
CEO
39 reports
Micah Benson
Chief Scientific Officer
17 reports
Patricia Harris
Senior Vice President
10 reports
Chris Heberlig
Chief Financial Officer
4 reports
Thomas Leitch
Chief Technology Officer
3 reports
Anna Truppel-Hartmann
Chief Medical Officer
Board
Doug Cole
Board Member
Theo Melas-Kyriazi
Chairman
Frank Stegmeier
Board Member
Mahesh Karande
Board Member
Alan Crane
Board Member
Richard Moscicki
Board Member
Jobs at KSQ Therapeutics
No open positions right now. Explore more companies on TheJobsMap.